Metraipolis › archive › dc_754a82f61589

A Theileria annulata parasite with a single mutation, methionine 128 to isoleucine (M128I), in cytochrome B is resistant to buparvaquone — Europe PMC PMID:38626086

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38626086
DOI
10.1371/journal.pone.0299002
License (as archived)
CC0-1.0
Archived
2026-10-06T18:47:40.935Z
SHA-256 of the archived text
a2ef5be9165c0d7df83ee61552f4569d53b4a7475e5a817d1b6b6e14731399b9
Stable URL of this page
https://metraipolis.com/documento/dc_754a82f61589

How to cite

A Theileria annulata parasite with a single mutation, methionine 128 to isoleucine (M128I), in cytochrome B is resistant to buparvaquone — Europe PMC PMID:38626086 — Europe PMC (en), https://europepmc.org/article/MED/38626086 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_754a82f61589 (Metraipolis archive dc_754a82f61589, sha256 a2ef5be9165c0d7df83ee61552f4569d53b4a7475e5a817d1b6b6e14731399b9)
BibTeX
@misc{dc754a82f61589,
  title = {A Theileria annulata parasite with a single mutation, methionine 128 to isoleucine (M128I), in cytochrome B is resistant to buparvaquone — Europe PMC PMID:38626086},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38626086},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_754a82f61589; sha256 a2ef5be9165c0d7df83ee61552f4569d53b4a7475e5a817d1b6b6e14731399b9},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38626086. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Tropical theileriosis is a fatal leukemic-like disease of cattle caused by the tick-transmitted protozoan parasite Theileria annulata. The economics of cattle meat and milk production is severely affected by theileriosis in endemic areas. The hydroxynaphtoquinone buparvaquone (BPQ) is the only available drug currently used to treat clinical theileriosis, whilst BPQ resistance is emerging and spreading in endemic areas. Here, we chronically exposed T. annulata-transformed macrophages in vitro to BPQ and monitored the emergence of drug-resistant parasites. Surviving parasites revealed a significant increase in BPQ IC50 compared to the wild type parasites. Drug resistant parasites from two independent cloned lines had an identical single mutation, M128I, in the gene coding for T. annulata cytochrome B (Tacytb). This in vitro generated mutation has not been reported in resistant field isolates previously, but is reminiscent of the methionine to isoleucine mutation in atovaquone-resistant Plasmodium and Babesia. The M128I mutation did not appear to exert any deleterious effect on parasite fitness (proliferation and differentiation to merozoites). To gain insight into whether drug-resistance could have resulted from altered drug binding to TaCytB we generated in silico a 3D-model of wild type TaCytB and docked BPQ to the predicted 3D-structure. Potential binding sites cluster in four areas of the protein structure including the Q01 site. The bound drug in the Q01 site is expected to pack against an alpha helix, which included M128, suggesting that the change in amino acid in this position may alter drug-binding. The in vitro generated BPQ resistant T. annulata is a useful tool to determine the contribution of the various predicted docking sites to BPQ resistance and will also allow testing novel drugs against theileriosis for their potential to overcome BPQ resistance.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-04-16).
Identificativi: PMID 38626086 · PMCID PMC11020719 · DOI 10.1371/journal.pone.0299002.
Descrittori MeSH principali: Ticks; Parasites; Theileria annulata; Theileriasis; Naphthoquinones; Antiprotozoal Agents.
Pagina: https://europepmc.org/article/MED/38626086 — https://doi.org/10.1371/journal.pone.0299002. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T17:12:53.322Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.